Recruiting NA Prematurity

New treatment option for Prematurity

Official title Preterm Donor Human Milk Supplementation of Mother's Own Milk in VLBW Infants

ClinicalTrials.gov ID: NCT05675397

What this study is testing

What it's testing
This prospective randomized controlled trial aims to investigate whether feeding very low birth weight (VLBW) infants with Mother's own milk (MOM) supplemented with either preterm (PDM) or term donor milk (TDM), when MOM is insufficient, has a positive impact on infants' protein intake, growth and morbidity.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 1 to 3

You may be able to join if

  • VLBW infants with birth weight \<1500g born to mothers who agree to provide donor milk for the first three weeks of life (donor milk period) if their...

You likely can't join if

  • Congenital anomalies
  • Chromosomal disorders
  • Metabolic diseases
  • Feeding with formula at any point during the first 3 weeks of life (donor milk period)

The study team makes the final eligibility decision.

Where it's taking place

  • Athens, Greece

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 1 day to 3 weeks. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Athens, Greece. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.